ANTIRETROVIRALS
T-20 launched in UK
Following approval in the EU on 28 May, T-20 (enfuvirtide, Fuzeon), was launched in the UK on 3 July 2003. It is the first of a new class of entry inhibitors, and results from studies in treatment experienced patients have been closely reported previously in HTB.
Links:
EMEA European Public Assessment Reports
http://www.emea.eu.int/humandocs/Humans/EPAR/fuzeon/fuzeon.htm
Roche press release
http://www.roche.com/med-corp-detail-2003?id=990&media-language=e
Enfuvirtide (T-20): predicting success and modelling survival benefits
|
HIV
Treatment Bulletin Vol 4 No7 August / September 2003
|
|
|
 |
